Hexosamines as mediators of nutrient sensing: Relevance to obesity, insulin resistance, and diabetes

Current Opinion in Endocrinology and Diabetes

Volumn 8, Issue 4, 2001, Pages 186-191

  McClain, D A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; INSULIN; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ADAPTATION; FATTY ACID SYNTHESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOSYLATION; HORMONE SYNTHESIS; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIVER METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OVERNUTRITION; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; SATIETY; TRANSGENIC MOUSE;

EID: 0034908691     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200108000-00004     Document Type: Review

References (61)

1. Molecular cloning, cDNA sequence, and bacterial expression of human glutamine: Fructose-6-phosphate amidotransferase
2. Human glutamine: Fructose-6-phosphate amidotransferase: Characterization of mRNA and chromosomal assignment to 2p13
3. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance
4. Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: Fructose-6-phosphate amidotransferase in rat-1 fibroblasts
5. Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor
6. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
7. A nutrient-sensing pathway regulates leptin gene expression in muscle and fat
8. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity
9. In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: Possible relevance to the maladaptive responses to chronic hyperglycaemia
10. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues
11. Role of the glucosamine pathway in fat-induced insulin resistance
12. Overexpression of glutamine: Fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance
13. Hexosamines stimulate leptin production in transgenic mice
14. Overexpression of glutamine: Fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance
15. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine: Fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione
16. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance
17. Glutamine: Fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: Relation to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin
18. Hexosamines regulate leptin production in human subcutaneous adipocytes
19. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production
20. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin-dependent diabetes mellitus
21. Effects of glucosamine infusion on insulin secretion and insulin action in humans
22. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle
23. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle
24. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes
25. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle
26. Enhanced protein O-GlcNAcylation is associated with insulin resistance in GLUT1 overexpressing mouse muscle
27. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
28. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
29. The hormone resistin links obesity to diabetes
30. Acute and chronic effects of hyperglycaemia on glucose metabolism: Implications for the development of new therapies
31. Beta-cell hyperresponsiveness: Earliest event in development of diabetes in monkeys
32. Fasting hyperinsulinemia predicts diabetes independently of insulin resistance and is associated with a polymorphism in PPARγ
33. Obesity-independent hyperinsulinemia in nondiabetic first-degree relatives of individuals with type 2 diabetes
34. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus. Influence of body weight
35. Basal plasma insulin levels exert a qualitative but not quantitative effect on glucose-mediated glucose uptake
36. Comparison of insulin sensitivity in patients with insulinoma and obese Type 2 diabetes mellitus
37. Production of insulin resistance by hyperinsulinaemia in man
38. Mechanisms of insulin resistance in experimental hyperinsulinemic dogs
39. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats
40. Exogenous hyperinsulinemia causes insulin resistance, hyperendothelinemia, and subsequent hypertension in rats
41. Chronic exogenous hyperinsulinemia in pregnancy: A rat model of pregnancy-induced hypertension
42. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
43. Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway
44. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells
45. Transcriptional regulation of transforming growth factor beta1 by glucose: Investigation into the role of the hexosamine biosynthesis pathway
46. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
47. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells
48. Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level
49. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc
50. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
51. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity
52. O-GlcNAc and the control of gene expression
53. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc AND O-phosphate
54. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas
55. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions
56. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility
57. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
58. UDP-N-acetylglucosamine transferase and glutamine: Fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues
59. Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells
60. SPINDLY, a tetratricopeptide repeat protein involved in gibberellin signal transduction in Arabidopsis
61. Differential effects of troglitazone and D-chiroinositol on glucosamine-induced insulin resistance in vivo in rats